Literature DB >> 5169924

Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report.

J G Tolentino, J N Rodriquez, R M Abalos.   

Abstract

Mesh：

Substances：

Year:  1971        PMID： 5169924

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN： 0148-916X


× No keyword cloud information.
  2 in total

1.  Identification of crystals of the rimino-phenazine compound B663 (Lamprene: clofazimine) in mouse spleen macrophages by thin layer chromatography and mass spectrum analysis.

Authors:  R T Aplin; A C McDougall
Journal:  Experientia       Date:  1975-04-15

2.  Peripheral Neuropathy Due to Leprosy.

Authors:  Sharon P. Nations; Richard J. Barohn
Journal:  Curr Treat Options Neurol       Date:  2002-05       Impact factor: 3.972
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.